SOBR Safe, Inc. (NASDAQ:SOBR – Get Free Report) traded up 1.8% during mid-day trading on Friday . The stock traded as high as $0.4498 and last traded at $0.4279. 99,914 shares changed hands during trading, a decline of 61% from the average session volume of 256,960 shares. The stock had previously closed at $0.4205.
Analyst Ratings Changes
SOBR has been the topic of several analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SOBR Safe in a report on Wednesday, July 29th. Wall Street Zen upgraded shares of SOBR Safe to a “sell” rating in a research note on Saturday, August 1st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, SOBR Safe has a consensus rating of “Sell”.
View Our Latest Research Report on SOBR
SOBR Safe Price Performance
SOBR Safe (NASDAQ:SOBR – Get Free Report) last released its quarterly earnings data on Friday, August 14th. The company reported ($1.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($220.00) by $218.92. SOBR Safe had a negative net margin of 2,924.23% and a negative return on equity of 314.39%. The company had revenue of $0.03 million during the quarter, compared to analysts’ expectations of $0.53 million.
Institutional Inflows and Outflows
A hedge fund recently bought a new position in SOBR Safe stock. Citadel Advisors LLC bought a new position in SOBR Safe, Inc. (NASDAQ:SOBR – Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 19,272 shares of the company’s stock, valued at approximately $67,000. Citadel Advisors LLC owned about 1.27% of SOBR Safe at the end of the most recent reporting period. 7.93% of the stock is owned by institutional investors.
SOBR Safe Company Profile
SOBR Safe, Inc (NASDAQ: SOBR) is a technology company specializing in the development and commercialization of cognitive impairment monitoring solutions. The company’s flagship offerings consist of handheld breath alcohol screening devices and integrated cognitive assessment tools designed to detect impairment in real time. SOBR Safe’s product line pairs portable breathalyzers with proprietary software that captures, records and analyzes impairment data to help organizations maintain safety and compliance standards.
Founded in 2020 and headquartered in Vancouver, Canada, SOBR Safe has focused on research and development of non-invasive impairment detection technology.
Further Reading
- Five stocks we like better than SOBR Safe
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for SOBR Safe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOBR Safe and related companies with MarketBeat.com's FREE daily email newsletter.
